ATE291929T1 - Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung - Google Patents

Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung

Info

Publication number
ATE291929T1
ATE291929T1 AT98929003T AT98929003T ATE291929T1 AT E291929 T1 ATE291929 T1 AT E291929T1 AT 98929003 T AT98929003 T AT 98929003T AT 98929003 T AT98929003 T AT 98929003T AT E291929 T1 ATE291929 T1 AT E291929T1
Authority
AT
Austria
Prior art keywords
surfactant
delivery
compositions
production
methods
Prior art date
Application number
AT98929003T
Other languages
English (en)
Inventor
Alexander V Kabanov
Adi Eisenberg
Victor A Kabanov
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Application granted granted Critical
Publication of ATE291929T1 publication Critical patent/ATE291929T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5138Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT98929003T 1997-06-13 1998-06-11 Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung ATE291929T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5300097P 1997-06-13 1997-06-13
PCT/US1998/012139 WO1998056334A1 (en) 1997-06-13 1998-06-11 Compositions for delivery of biological agents and methods for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE291929T1 true ATE291929T1 (de) 2005-04-15

Family

ID=21981274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929003T ATE291929T1 (de) 1997-06-13 1998-06-11 Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung

Country Status (7)

Country Link
EP (1) EP1005324B1 (de)
JP (1) JP2002504123A (de)
AT (1) ATE291929T1 (de)
AU (1) AU8067198A (de)
CA (1) CA2294334A1 (de)
DE (1) DE69829570T2 (de)
WO (1) WO1998056334A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803517A1 (fr) * 2000-01-12 2001-07-13 Biovector Therapeutics Sa Matrices plymeriques amphiphiles et ioniques et derives de telles matrices
FR2803526A1 (fr) * 2000-01-12 2001-07-13 Biovector Therapeutics Matrices polymeriques amphiphiles et ioniques et derives de telles matrices
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
EP1480680B1 (de) 2002-03-07 2010-11-03 Biocompatibles UK Limited Mit nucleinsäure complexierte block-copolymere
US7332527B2 (en) 2003-05-16 2008-02-19 Board Of Regents Of The University Of Nebraska Cross-linked ionic core micelles
WO2004105799A1 (ja) * 2003-05-29 2004-12-09 Toudai Tlo, Ltd. 安定化高分子ミセル
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
MXPA06013437A (es) 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
WO2011105520A1 (ja) * 2010-02-26 2011-09-01 国立大学法人 長崎大学 抗原または薬物送達複合体
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
US9498533B2 (en) 2011-04-04 2016-11-22 Board Of Regents Of The University Of Nebraska Drug delivery compositions and methods
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
IL305353A (en) * 2021-02-26 2023-10-01 Ethris Gmbh Formulations for aerosol formation and aerosols for the delivery of nucleic acid
CN118255984B (zh) * 2024-04-08 2025-02-11 临沂中磷生物科技有限公司 一种促生根的聚谷氨酸衍生物的制备方法、装置及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
JPH08165491A (ja) * 1994-12-16 1996-06-25 Lion Corp 高分子とアニオン界面活性剤との複合体

Also Published As

Publication number Publication date
DE69829570D1 (de) 2005-05-04
EP1005324A4 (de) 2001-06-06
JP2002504123A (ja) 2002-02-05
EP1005324B1 (de) 2005-03-30
CA2294334A1 (en) 1998-12-17
AU8067198A (en) 1998-12-30
WO1998056334A1 (en) 1998-12-17
EP1005324A1 (de) 2000-06-07
DE69829570T2 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
ATE291929T1 (de) Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung
TR199700786T1 (xx) Kat� aktif madde bile�imleri.
EG19564A (en) Shampoo compositions with silicone and cationic polymeric conditioning agents
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
DE69635496D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
DE68907397D1 (de) Fluessige photopolymerisierbare zusammensetzung, viskoelastisches produkt, erhalten aus dieser zusammensetzung und verfahren zur herstellung dieses viskoelastischen produktes.
DE68908211D1 (de) Dispersionsmittel fuer zement, verfahren zu ihrer herstellung und verfahren zum verleihen von fluidisierungseigenschaften an diese mittel enthaltende hydraulische zementzusammensetzungen.
DE69942610D1 (de) Die bindung von integrinen zu deren rezeptoren verhindernde verbindungen
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
EP0231752A3 (de) Peptide mit vasorelaxierender, natriuretischer und diuretischer Wirkung, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
ATE203392T1 (de) Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
WO1996028468A3 (en) Amphiphilic peptide and analogs thereof
ES2171976T3 (es) Formulacion de ciclosporina.
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE69007047D1 (de) Lagerstabile feste Isocyanatzusammensetzungen, ihre Herstellung und Verfahren zu ihrer Verwendung.
RU98122064A (ru) Моющие косметические композиции для волос и их применение
MX9708091A (es) Metodo de elaboracion de un alimento para animales que tiene una suspension estable de psyllium.
ATE231486T1 (de) Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock
BR9609114A (pt) Composição inseticida de terra diatomácea
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
WO1997008931A3 (de) Extraktionsmittel für polyhydroxyalkansäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties